BG
MLNT

Bellevue Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bellevue Group’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,420
Closed -$507K – 136
2017
Q4 		$507K Buy
+6,420
New +$507K 0.05% 124